Tissue Genesis, Inc

HONOLULU, HI · Biotech · Acquired

Automated point-of-care device that extracts adult stem cells from adipose tissue

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · tissuegenesis.com

Sector: Biotech
Headquarters: HONOLULU, HI
Latest Form D: $500K, Sep 2014
Total capital: $26.1M

Federal grants: $997K; 1 award · 2015; Rank in peer group#16 of 17
Private capital raised: $20.9M; 7 Form D · last Sep 2014; 146 months since last filing
Federal contracts: $4.2M; 4 awards · Defense, NASA; Rank in Biotech#94 of 4373
Granted patents: 0; 11 pending

Capital timeline

Latest events

Feb 2018Federal contractNASA · NASA Bioculture System$11K
Jun 2015Federal grantDefense · Phase II · Handheld Adipose Stem Cell Processor for Point of Care Application$997K
Sep 2014Private capital raisedForm D · SEC · 7th filing$500K
Dec 2013Federal contractDefense · Igf::ot::igf SBIR Army Phase I Proposal A132-087-0015$1.1M
Jul 2012Federal contractNASA · Igf::ot::igf Modification Of The Iss Cell Culture Module.$2.9M
Jan 2012Private capital raisedForm D · SEC · 6th filing$7.7M
Jul 2011Private capital raisedForm D · SEC · 5th filing$5.6M
Jan 2011Private capital raisedForm D · SEC · 4th filing$4.5M
Jul 2010Private capital raisedForm D · SEC · 3rd filing$1.3M
Apr 2010Private capital raisedForm D · SEC · 2nd filing$1.1M
Apr 2010Private capital raisedForm D · SEC · 1st filing$120K

Show 1 earlier federal award

Jun 2011Federal contractDefense · Bioreactors For Shuttle Launch$124K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 17 peers

Line = median

Biotech · Device

Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings

Anton C KruckyExecutive Officer, DirectorNamed in SEC Form D filings
Bradley C. PerkinsExecutive Officer, DirectorNamed in SEC Form D filings
Hiam RobertDirectorNamed in SEC Form D filings
Jeffery C WatanabeDirectorNamed in SEC Form D filings
Jeffrey C WatanabeDirectorNamed in SEC Form D filings
Jeff C. WatanabeDirectorNamed in SEC Form D filings

Show all 13 people

Lawrence C. RodriguezDirectorNamed in SEC Form D filings
Michael C. RuleyDirectorNamed in SEC Form D filings
Paul C. KosnikExecutive OfficerNamed in SEC Form D filings
Robert C HiamDirectorNamed in SEC Form D filings
Thomas C. CannonExecutive Officer, DirectorNamed in SEC Form D filings
Timothy C. SarhattDirectorNamed in SEC Form D filings
William C WiesmannDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 11

Jan 1, 2015PendingMethods For Preparing Cell Delivery MatricesUSPTOApplication 14487483
Jul 24, 2014PendingHand-held Adipose Processor And Cell ConcentratorUSPTOApplication 14221272
Jan 2, 2014PendingFormation Of Cell AggregatesUSPTOApplication 13843814

Show all 11 patent records

Methods For Preparing Cell Delivery MatricesJan 1, 2015 · Application 14487483Pending
Hand-held Adipose Processor And Cell ConcentratorJul 24, 2014 · Application 14221272Pending
Formation Of Cell AggregatesJan 2, 2014 · Application 13843814Pending
Adipose-derived Stromal Cells (asc) As Delivery Tool For Treatment Of CancerApplication PCTUS2010042612Pending
Adipose Tissue Collection And Pre-processing Devices For Use In Liposuction ProcedureApplication PCTUS2010033940Pending
Methods And Compositions To Support Tissue Integration And Inosculation Of Transplanted Tissue And Transplanted Engineered Penile Tissue With Adipose Stromal CellsApplication PCTUS2010026407Pending
Cell Separation Apparatus And Methods Of UseApplication PCTUS2008005181Pending
Hand-held Adipose Processor And Cell ConcentratorApplication PCTUS2015021481Pending
Apparatus And Methods For Preparing Tissue GraftsApplication PCTUS2006027191Pending
Hand-held Micro-liposuction Adipose Harvester, Processor, And Cell ConcentratorApplication PCTUS2013060747Pending
Formation Of Cell AggregatesApplication PCTUS2013048788Pending

BIOINFOEXPERTS LLCSimilar federal contract value in Biotech · $4.3M in contracts
A&G PHARMACEUTICAL, INC.Similar federal contract value in Biotech · $4.2M in contracts
UNIVERSAL STABILIZATION TECHNOLOGIES, INC.Similar federal contract value in Biotech · $4.2M in contracts
ALAMAR BIOSCIENCES, INC.Similar federal contract value in Biotech · $4.1M in contracts
CAIRN BIOSCIENCES INCSimilar federal contract value in Biotech · $4M in contracts
CELDARA MEDICAL, LLCSimilar federal contract value in Biotech · $4M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.